Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Interest Coverage Ratio: 2012-2025

Historic Interest Coverage Ratio for Cytokinetics (CYTK) over the last 9 years, with Sep 2025 value amounting to -14.69.

  • Cytokinetics' Interest Coverage Ratio rose 6.86% to -14.69 in Q3 2025 from the same period last year, while for Sep 2025 it was -15.04, marking a year-over-year decrease of 3.01%. This contributed to the annual value of -14.22 for FY2024, which is 18.86% up from last year.
  • According to the latest figures from Q3 2025, Cytokinetics' Interest Coverage Ratio is -14.69, which was down 16.81% from -12.57 recorded in Q2 2025.
  • Over the past 5 years, Cytokinetics' Interest Coverage Ratio peaked at -3.87 during Q2 2022, and registered a low of -28.35 during Q1 2022.
  • For the 3-year period, Cytokinetics' Interest Coverage Ratio averaged around -15.67, with its median value being -16.45 (2023).
  • In the last 5 years, Cytokinetics' Interest Coverage Ratio crashed by 1,375.55% in 2021 and then soared by 71.21% in 2022.
  • Cytokinetics' Interest Coverage Ratio (Quarterly) stood at -5.15 in 2021, then plummeted by 249.83% to -18.00 in 2022, then climbed by 1.19% to -17.79 in 2023, then rose by 12.54% to -15.56 in 2024, then rose by 6.86% to -14.69 in 2025.
  • Its Interest Coverage Ratio stands at -14.69 for Q3 2025, versus -12.57 for Q2 2025 and -15.56 for Q4 2024.